Loading...
•
Dec 31, 2023
TherapeuticsMD Q4 2023 Earnings Report
TherapeuticsMD reported financial results for the full year ended December 31, 2023.
Key Takeaways
TherapeuticsMD, a pharmaceutical royalty company, reported full year 2023 financial results and continues to explore strategic alternatives to maximize shareholder value.
Reported financial results for the full year ended December 31, 2023.
Exploring strategic alternatives to maximize value for shareholders.
Company is primarily collecting royalties from its licensees.
Company is no longer engaging in research and development or commercial operations.
TherapeuticsMD
TherapeuticsMD
TherapeuticsMD Revenue by Segment
Revenue by Segment
License Revenue
CapyFin.com Forward Guidance
TherapeuticsMD is exploring potential strategic alternatives that may include an acquisition, merger, other business combination, sale of assets, or other strategic transactions.